News
Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market
Hi, what are you looking for?
Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market
With a massive $164.7M Q3 loss and a second round of cuts, the Edmonton producer is illustrative of troubles in the Canadian cannabis industry
In the final quarter before merging with Aphria, Tilray shows fiscal weakness
But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market
The Canadian pot product company says its Green Roads deal represents only the first step in its US expansion strategy
The Canadian weed firm urges all shareholders to weigh in on the vote, which has been delayed to April 30
CEO Simon says he expects to capture 30% of a $6B Canadian market following the Tilray merger and pandemic lifting
Although the Canadian company leads across several categories and jurisdictions, it's battling against price compression and packaging costs to win
While Canopy says its building authentic brands, weed industry insiders criticize the pot giant for attempting to buy brand loyalty instead of earning it
Once its deal to buy Zenabis closes, Hexo says it will be close to top-2 in Canadian recreational weed sales
